Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1992 Dec 1;176(6):1497–1502. doi: 10.1084/jem.176.6.1497

Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease

PMCID: PMC2119445  PMID: 1460414

Abstract

Serum mannose-binding protein (MBP) is a C-type lectin that binds to terminal mannose and N-acetylglucosamine moieties present on surfaces of certain pathogens and activates the classical complement pathway. In the present study, we describe the mechanism underlying the activation triggered by MBP. The human serum MBP fraction was obtained by sequential affinity chromatography on mannan-Sepharose, anti-IgM- Sepharose and anti-MBP-Sepharose in the presence of calcium ions. This fraction contained a C1s-like serine protease as assessed by C4 consumption. The C1s-like serine protease, designated MBP-associated serine protease (MASP), was separated from MBP by rechromatography on anti-MBP-Sepharose in the presence of ethylenediaminetetraacetic acid. MASP exhibited both C4- and C2-consuming activities. The molecular mass of MASP was estimated to be 83 kD with two polypeptides of heavy (66 kD) and light (L) (31 kD) chains linked by disulfide bonds. The serine residue responsible for protease activity is located on the L chain. Reconstitution experiments using MASP and MBP revealed that combination of the two components restores C4- and C2-activating capacity on mannan. Based on analyses of molecular size, antigenicity, and 11 NH2- terminal amino acid sequences of the L chain, we conclude that MASP is a novel protein different from C1r or C1s. Our findings are not in accord with a proposed mechanism by which MBP utilizes the C1r2-C1s2 complex to initiate the classical complement pathway.

Full Text

The Full Text of this article is available as a PDF (732.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Drickamer K. Two distinct classes of carbohydrate-recognition domains in animal lectins. J Biol Chem. 1988 Jul 15;263(20):9557–9560. [PubMed] [Google Scholar]
  2. Ezekowitz R. A., Day L. E., Herman G. A. A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins. J Exp Med. 1988 Mar 1;167(3):1034–1046. doi: 10.1084/jem.167.3.1034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ezekowitz R. A., Kuhlman M., Groopman J. E., Byrn R. A. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med. 1989 Jan 1;169(1):185–196. doi: 10.1084/jem.169.1.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gigli I., Porter R. R., Sim R. B. The unactivated form of the first component of human complement, C1. Biochem J. 1976 Sep 1;157(3):541–548. doi: 10.1042/bj1570541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ihara I., Harada Y., Ihara S., Kawakami M. A new complement-dependent bactericidal factor found in nonimmune mouse sera: specific binding to polysaccharide of Ra chemotype Salmonella. J Immunol. 1982 Mar;128(3):1256–1260. [PubMed] [Google Scholar]
  6. Ihara I., Ihara S., Nagashima A., Ji Y. H., Kawakami M. The 28k and 70k dalton polypeptide components of mouse Ra-reactive factor are responsible for bactericidal activity. Biochem Biophys Res Commun. 1988 Apr 29;152(2):636–641. doi: 10.1016/s0006-291x(88)80086-x. [DOI] [PubMed] [Google Scholar]
  7. Ihara I., Ueda H., Suzuki A., Kawakami M. Physicochemical properties of a new bactericidal factor, Ra-reactive factor. Biochem Biophys Res Commun. 1982 Aug 31;107(4):1185–1190. doi: 10.1016/s0006-291x(82)80122-8. [DOI] [PubMed] [Google Scholar]
  8. Ihara S., Takahashi A., Hatsuse H., Sumitomo K., Doi K., Kawakami M. Major component of Ra-reactive factor, a complement-activating bactericidal protein, in mouse serum. J Immunol. 1991 Mar 15;146(6):1874–1879. [PubMed] [Google Scholar]
  9. Ikeda K., Sannoh T., Kawasaki N., Kawasaki T., Yamashina I. Serum lectin with known structure activates complement through the classical pathway. J Biol Chem. 1987 Jun 5;262(16):7451–7454. [PubMed] [Google Scholar]
  10. Ji Y. H., Matsushita M., Okada H., Fujita T., Kawakami M. The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor. J Immunol. 1988 Dec 15;141(12):4271–4275. [PubMed] [Google Scholar]
  11. Kawakami M., Ihara I., Ihara S., Suzuki A., Fukui K. A group of bactericidal factors conserved by vertebrates for more than 300 million years. J Immunol. 1984 May;132(5):2578–2581. [PubMed] [Google Scholar]
  12. Kawakami M., Ihara I., Suzuki A., Harada Y. Properties of a new complement-dependent bactericidal factor specific for Ra chemotype salmonella in sera of conventional and germ-free mice. J Immunol. 1982 Nov;129(5):2198–2201. [PubMed] [Google Scholar]
  13. Kawasaki N., Kawasaki T., Yamashina I. A serum lectin (mannan-binding protein) has complement-dependent bactericidal activity. J Biochem. 1989 Sep;106(3):483–489. doi: 10.1093/oxfordjournals.jbchem.a122878. [DOI] [PubMed] [Google Scholar]
  14. Kawasaki N., Kawasaki T., Yamashina I. Mannan-binding protein and conglutinin in bovine serum. J Biochem. 1985 Nov;98(5):1309–1320. doi: 10.1093/oxfordjournals.jbchem.a135398. [DOI] [PubMed] [Google Scholar]
  15. Kozutsumi Y., Kawasaki T., Yamashina I. Isolation and characterization of a mannan-binding protein from rabbit serum. Biochem Biophys Res Commun. 1980 Jul 31;95(2):658–664. doi: 10.1016/0006-291x(80)90836-0. [DOI] [PubMed] [Google Scholar]
  16. Kuhlman M., Joiner K., Ezekowitz R. A. The human mannose-binding protein functions as an opsonin. J Exp Med. 1989 May 1;169(5):1733–1745. doi: 10.1084/jem.169.5.1733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kusumoto H., Hirosawa S., Salier J. P., Hagen F. S., Kurachi K. Human genes for complement components C1r and C1s in a close tail-to-tail arrangement. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7307–7311. doi: 10.1073/pnas.85.19.7307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  19. Larkin M., Childs R. A., Matthews T. J., Thiel S., Mizuochi T., Lawson A. M., Savill J. S., Haslett C., Diaz R., Feizi T. Oligosaccharide-mediated interactions of the envelope glycoprotein gp120 of HIV-1 that are independent of CD4 recognition. AIDS. 1989 Dec;3(12):793–798. doi: 10.1097/00002030-198912000-00003. [DOI] [PubMed] [Google Scholar]
  20. Lu J. H., Thiel S., Wiedemann H., Timpl R., Reid K. B. Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q. J Immunol. 1990 Mar 15;144(6):2287–2294. [PubMed] [Google Scholar]
  21. Malhotra R., Thiel S., Reid K. B., Sim R. B. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med. 1990 Sep 1;172(3):955–959. doi: 10.1084/jem.172.3.955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Matsushita M., Okada H. Alternative complement pathway activation by C4b deposited during classical pathway activation. J Immunol. 1986 Apr 15;136(8):2994–2998. [PubMed] [Google Scholar]
  23. Matsushita M., Okada H. Two forms of guinea pig factor B of the alternative complement pathway with different molecular weights. Mol Immunol. 1989 Jul;26(7):669–676. doi: 10.1016/0161-5890(89)90050-3. [DOI] [PubMed] [Google Scholar]
  24. Matsushita M., Takahashi A., Hatsuse H., Kawakami M., Fujita T. Human mannose-binding protein is identical to a component of Ra-reactive factor. Biochem Biophys Res Commun. 1992 Mar 16;183(2):645–651. doi: 10.1016/0006-291x(92)90531-o. [DOI] [PubMed] [Google Scholar]
  25. Nagasawa S., Stroud R. M. Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b. Proc Natl Acad Sci U S A. 1977 Jul;74(7):2998–3001. doi: 10.1073/pnas.74.7.2998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ohta M., Okada M., Yamashina I., Kawasaki T. The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein. J Biol Chem. 1990 Feb 5;265(4):1980–1984. [PubMed] [Google Scholar]
  27. Oka S., Ikeda K., Kawasaki T., Yamashina I. Isolation and characterization of two distinct mannan-binding proteins from rat serum. Arch Biochem Biophys. 1988 Jan;260(1):257–266. doi: 10.1016/0003-9861(88)90448-1. [DOI] [PubMed] [Google Scholar]
  28. Schweinle J. E., Ezekowitz R. A., Tenner A. J., Kuhlman M., Joiner K. A. Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella. J Clin Invest. 1989 Dec;84(6):1821–1829. doi: 10.1172/JCI114367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Super M., Levinsky R. J., Turner M. W. The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations. Clin Exp Immunol. 1990 Feb;79(2):144–150. doi: 10.1111/j.1365-2249.1990.tb05170.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Super M., Thiel S., Lu J., Levinsky R. J., Turner M. W. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet. 1989 Nov 25;2(8674):1236–1239. doi: 10.1016/s0140-6736(89)91849-7. [DOI] [PubMed] [Google Scholar]
  31. Weis W. I., Kahn R., Fourme R., Drickamer K., Hendrickson W. A. Structure of the calcium-dependent lectin domain from a rat mannose-binding protein determined by MAD phasing. Science. 1991 Dec 13;254(5038):1608–1615. doi: 10.1126/science.1721241. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES